Pharmaceutical company, parent of EMD Serono
3 AI-extracted insights from 2 sources — podcasts, YouTube channels, and X/Twitter accounts.
Based on 2 scored insights about Merck KGaA.
The 2 sources with the most insights about Merck KGaA on Kazuha.
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Merck KGaA was reported to be acquiring Silence Therapeutics, but no deal terms or investment analysis were provided.
Mentioned as the acquirer of Silence Therapeutics; no specific investment outlook or deal terms were provided.
Mentioned as the parent of a company said to have agreed to 'massive discounts' on drugs under a proposed policy, representing a significant risk to revenue.
Merck KGaA was reported to be acquiring Silence Therapeutics, but no deal terms or investment analysis were provided.
Mentioned as the acquirer of Silence Therapeutics; no specific investment outlook or deal terms were provided.
Mentioned as the parent of a company said to have agreed to 'massive discounts' on drugs under a proposed policy, representing a significant risk to revenue.
Other assets that creators frequently mention in the same content as Merck KGaA.
The most active sources covering Merck KGaA (MKKGY) on Kazuha are @realmartinshkreli, @theshkrelipill. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
Kazuha has indexed 3 AI-extracted insights about Merck KGaA (MKKGY) from 2 different sources. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
Creators covering Merck KGaA (MKKGY) most frequently also discuss IONQ, V, ZURA, INTC, PG. See the "Discussed alongside" section above for full asset pages.